Adecto Pharmaceuticals is a pre-clinical stage company, developing a therapeutic and diagnostic for cancers that express the cell surface ADAM8 protein. ADAM8 is a critical driver of the growth and spread of many aggressive tumors, including those of the breast, colon, kidneys, liver and lungs, and is associated with poor patient survival. If you are interested in learning more, please visit us at www.adectopharma.com

Adecto Pharmaceuticals

Gail SONENSHEIN

This department is responsible for setting the strategic direction and overseeing the overall operations of the organization.

Adecto Pharmaceuticals

Org chart

Teams

Executive Leadership

Offices